[Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
Tamura
A
A
Dept. of Respiratory Medicine, Tokyo National Hospital.
Mikami
A
A
Sagara
Y
Y
Hebisawa
A
A
D000230:Adenocarcinoma / Q000188:drug therapy / Q000532:radiotherapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000532:radiotherapy; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D011879:Radiotherapy Dosage; D014751:Vindesine / Q000008:administration & dosage
D002945:Cisplatin; D014751:Vindesine